UB Paderborn / Katalog / Suche / in CDI

Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease

European journal of clinical investigation, 2001-02, Vol.31 (2), p.131-137

2001

Volltextzugriff (PDF)

Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty

Arteriosclerosis, thrombosis, and vascular biology, 1997-11, Vol.17 (11), p.3208

1997

Volltextzugriff (PDF)

Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism

Circulation (New York, N.Y.), 1988-02, Vol.77 (2), p.353-360

1988

Volltextzugriff (PDF)

Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease

Atherosclerosis, 1999-01, Vol.142 (1), p.193-200

1999

Volltextzugriff (PDF)

Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease

Blood coagulation & fibrinolysis, 2000-03, Vol.11 (2), p.165-173

2000

Volltextzugriff (PDF)

Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation

The Journal of infectious diseases, 1989-09, Vol.160 (3), p.414

1989

Volltextzugriff (PDF)

Two consecutive pregnancies and deliveries in a patient with von Willebrand's disease type 3

Haemophilia : the official journal of the World Federation of Hemophilia, 1998-11, Vol.4 (6), p.845-849

1998

Volltextzugriff (PDF)

Clinical Pharmacology of Intravenously Administered Recombinant Desulfatohirudin (CGP 39393) in Healthy Volunteers

Journal of cardiovascular pharmacology, 1993-09, Vol.22 (3), p.364-372

1993

Volltextzugriff (PDF)

Prosthetic heart valves and rare hypersensitivity to vitamin K antagonists resulting from factor IX mutation: how to manage anticoagulation?

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-01, Vol.16 (1), p.187-189

2010

Volltextzugriff (PDF)

Influence of the genetic background on platelet function, microparticle and thrombin generation in the common laboratory mouse

Platelets (Edinburgh), 2001-12, Vol.12 (8), p.496-502

2001

Volltextzugriff (PDF)

The effect of nimesulide versus placebo on hemostasis in healthy volunteers

European journal of clinical pharmacology, 1998-07, Vol.54 (5), p.383-387

1998

Volltextzugriff (PDF)

Quantification of coagulation factors and inhibitors. Still a special task

Hämostaseologie, 2006-01, Vol.26 (1), p.38

Marbet, G A

2006

Volltextzugriff (PDF)

Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant

Thrombosis and haemostasis, 1989-04, Vol.61 (2), p.175

1989

Volltextzugriff (PDF)

Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis

Thrombosis research, 1989-07, Vol.55 (1), p.5-11

1989

Volltextzugriff (PDF)

Unexpected bleeding following eyelid tumor resection leading to the rare diagnosis of acquired haemophilia

Klinische Monatsblätter für Augenheilkunde, 2008-05, Vol.225 (5), p.424

2008

Volltextzugriff (PDF)

Lack of association between antiphospholipid antibodies and migraine

Thrombosis and haemostasis, 1993-05, Vol.69 (5), p.415

1993

Volltextzugriff (PDF)

Simvastatin reduces activation of normal platelets by LDL isolated from patients with familial hypercholesterolaemia and familial defective apolipoprotein B

European journal of clinical pharmacology, 1997, Vol.53 (3-4), p.277-279

1997

Volltextzugriff (PDF)

Anticardiolipin antibodies and coronary heart disease

European heart journal, 1992-12, Vol.13 (12), p.1645-1648

1992

Volltextzugriff (PDF)

Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin

Journal of rheumatology, 1990-06, Vol.17 (6), p.785

1990

Volltextzugriff (PDF)

CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR AND FACTOR VIII AFTER ELECTIVE HEART SURGERY IN A 12-YEAR-OLD GIRL WITH VON WILLEBRAND DISEASE TYPE 3

Pediatric hematology and oncology, 1999-11, Vol.16 (6), p.551-556

1999

Volltextzugriff (PDF)

Anticardiolipin antibodies are not associated with restenosis or endothelial activation after percutaneous transluminal angioplasty

International angiology, 1997-06, Vol.16 (2), p.88

1997

Volltextzugriff (PDF)

Platelet surface activation markers after DDAVP infusion in healthy subjects

Thrombosis and haemostasis, 1995-09, Vol.74 (3), p.991

1995

Volltextzugriff (PDF)

Anticardiolipin antibodies do not seem to be associated with APC resistance in vivo or in vitro

Annals of hematology, 1995-10, Vol.71 (4), p.195-198

1995

Volltextzugriff (PDF)

Lupus anticoagulants/anticardiolipin antibodies in patients with normal tension glaucoma

Blood coagulation & fibrinolysis, 1992-10, Vol.3 (5), p.541-546

1992

Volltextzugriff (PDF)

Gingival bleeding, epistaxis and haematoma three days after gastroenteritis : the haemorrhagic lupus anticoagulant syndrome

European journal of pediatrics, 2001, Vol.160 (1), p.43-46

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease

Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty

Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism

Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease

Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease

Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation

Two consecutive pregnancies and deliveries in a patient with von Willebrand's disease type 3

Clinical Pharmacology of Intravenously Administered Recombinant Desulfatohirudin (CGP 39393) in Healthy Volunteers

Prosthetic heart valves and rare hypersensitivity to vitamin K antagonists resulting from factor IX mutation: how to manage anticoagulation?

Influence of the genetic background on platelet function, microparticle and thrombin generation in the common laboratory mouse

The effect of nimesulide versus placebo on hemostasis in healthy volunteers

Quantification of coagulation factors and inhibitors. Still a special task

Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant

Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis

Unexpected bleeding following eyelid tumor resection leading to the rare diagnosis of acquired haemophilia

Lack of association between antiphospholipid antibodies and migraine

Simvastatin reduces activation of normal platelets by LDL isolated from patients with familial hypercholesterolaemia and familial defective apolipoprotein B

Anticardiolipin antibodies and coronary heart disease

Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin

CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR AND FACTOR VIII AFTER ELECTIVE HEART SURGERY IN A 12-YEAR-OLD GIRL WITH VON WILLEBRAND DISEASE TYPE 3

Anticardiolipin antibodies are not associated with restenosis or endothelial activation after percutaneous transluminal angioplasty

Platelet surface activation markers after DDAVP infusion in healthy subjects

Anticardiolipin antibodies do not seem to be associated with APC resistance in vivo or in vitro

Lupus anticoagulants/anticardiolipin antibodies in patients with normal tension glaucoma

Gingival bleeding, epistaxis and haematoma three days after gastroenteritis : the haemorrhagic lupus anticoagulant syndrome

Suchergebnisse filtern